Status | Study |
Terminated |
Study Name: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma Condition: Acral Lentiginous Malignant Melanoma Lentigo Maligna Malignant Melanoma Date: 2010-05-07 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Active, not recruiting |
Study Name: Dinaciclib in Treating Patients With Stage IV Melanoma Condition: Acral Lentiginous Melanoma Lentigo Maligna Melanoma Mucosa Date: 2009-07-10 Interventions: Drug: Dinaciclib Given IV Other Names: |
Recruiting |
Study Name: Study of Families With Melanoma Condition: Melanoma (Skin) Date: 2007-03-07 Interventions: Genetic: gene expression analysis Genetic: |
Completed |
Study Name: Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma Condition: Melanoma (Skin) Date: 2000-04-06 Interventions: Biological: adenovirus RSV-TK Drug: gancic |